Cargando…
Efficacy and safety of telbivudine treatment for the prevention of HBV perinatal transmission
To observe the efficacy of telbivudine in chronic hepatitis B (CHB) women with high viral load during pregnancy and the long-term effects on intelligence, growth, and development of the newborns. A total of 87 patients were included. Forty-two patients received telbivudine orally 600 mg per day and...
Autores principales: | Ren, Cuicui, Wang, Lili, Sun, Weihui, Ma, Lei, Dong, Zhi, Hao, Anhua, Zhou, Lin, Li, Fengzhu, Ma, Wenjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302680/ https://www.ncbi.nlm.nih.gov/pubmed/32541488 http://dx.doi.org/10.1097/MD.0000000000020583 |
Ejemplares similares
-
Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission
por: Sun, Weihui, et al.
Publicado: (2017) -
Comparison of the efficacy and safety of tenofovir and telbivudine in interrupting mother-to-child transmission of hepatitis B virus
por: Zhu, Bo, et al.
Publicado: (2021) -
Association between liver cirrhosis and estimated glomerular filtration rates in patients with chronic HBV infection
por: Wang, Dexin, et al.
Publicado: (2020) -
Effectiveness of tenofovir or telbivudine in preventing HBV vertical transmission for pregnancy
por: Zeng, Jianyong, et al.
Publicado: (2019) -
Efficacy and safety of Shufeng Jiedu capsule in the treatment of COVID-19: A protocol for systematic review and meta analysis
por: Ma, Li, et al.
Publicado: (2020)